Clinical trial
Treatment of Advanced Hodgkin's Disease (Stages IIB-III-IV)
NCT00443677 · Gruppo Italiano Studio Linfomi, Other · Completed
Key facts
| NCT number | NCT00443677 |
|---|---|
| Title | Treatment of Advanced Hodgkin's Disease (Stages IIB-III-IV) |
| Official title | Treatment of Advanced Hodgkin's Disease (Stages IIB-III-IV) |
| Acronym | HD2000 |
| Lead sponsor | Gruppo Italiano Studio Linfomi, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Advanced Hodgkin Disease |
| Intervention type | Drug |
| Interventions | COPPEBVCAD vs BEACOPP vs ABVD |
| Enrollment | 307 |
| Start date | Apr 1, 2000 |
| Completion | Jun 1, 2007 |
| First posted | Mar 6, 2007 |
| Last update posted | Mar 20, 2009 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: